Abstract
Expert Panel opinion «Possibilities of Cytoflavin in Patients with Diabetic Polyneuropathy» based on the results of the study «Efficacy and safety of combined metabolic medication containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multiple-center randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)»
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
